New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition

PISCATAWAY, N.J., January 10, 2006 - A study published in the December 2005 Journal of the International Society of Sports Nutrition ( entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract and the only known plant source of forskolin, promotes favorable changes in body composition.

The 12-week randomized, double-blind, placebo-controlled study of 23 overweight women conducted by researchers in the Exercise & Sport Nutrition Lab at the Center for Exercise, Nutrition & Preventive Health Research at Baylor University revealed that individuals receiving ForsLean showed decreases in body mass and reported less fatigue and hunger. Additionally, no clinically significant interactions were seen in metabolic markers, blood lipids, muscle and liver enzymes, electrolytes, red cells, white cells, hormones (insulin, TSH, T3, T4), heart rate or blood pressure. Study participants were given either 250 mg of ForsLean (standardized to 10 percent diterpene forskolin) or a placebo twice daily for 12 weeks.

"These study results indicate that ForsLean helps preserve lean body mass, improve body composition and mitigate weight gain in overweight females with no apparent side effects," stated Vladimir Badmaev, MD, Ph.D., vice president of scientific and medical affairs, Sabinsa Corporation.

ForsLean is an extract derived from Coleus forskohlii roots, and the only known plant source of forskolin, a natural compound that has been shown to increase lean body mass and help optimize body composition through cAMP activation. Sabinsa holds U.S. Patent #5,804,596 and European Patent #98 907 537 9 for the use of forskolin as a weight management and body composition ingredient and manufactures and supplies various extract strengths for use in a variety of supplements and products. Other international patents are pending. For more information visit

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.